Single nucleotide polymorphism of TAG-1 influences IVIg responsiveness of Japanese patients with CIDP
@article{Iijima2009SingleNP, title={Single nucleotide polymorphism of TAG-1 influences IVIg responsiveness of Japanese patients with CIDP}, author={M. Iijima and M. Tomita and S. Morozumi and Y. Kawagashira and T. Nakamura and H. Koike and M. Katsuno and N. Hattori and F. Tanaka and M. Yamamoto and G. Sobue}, journal={Neurology}, year={2009}, volume={73}, pages={1348 - 1352} }
Objective: Chronic inflammatory demyelinating polyneuropathy (CIDP) is characterized by immune-mediated peripheral demyelination. Although corticosteroid, IV immunoglobulin (IVIg) and plasma exchange have been established as the most effective therapeutics, subpopulations of patients show little or no response to either of these therapies. In this study, we examined whether particular genetic factors influence the therapeutic responsiveness of patients with CIDP. Methods: One hundred Japanese… CONTINUE READING
Topics from this paper
45 Citations
Polymorphism of transient axonal glycoprotein‐1 in chronic inflammatory demyelinating polyneuropathy
- Medicine
- Journal of the peripheral nervous system : JPNS
- 2011
- 10
Single‐nucleotide polymorphism of transient axonal glycoprotein‐1 and its correlation with clinical features and prognosis in chronic inflammatory demyelinating polyneuropathy
- Medicine
- Journal of the peripheral nervous system : JPNS
- 2012
- 7
Intravenous immunoglobulin response in treatment-naïve chronic inflammatory demyelinating polyradiculoneuropathy
- Medicine
- Journal of Neurology, Neurosurgery & Psychiatry
- 2014
- 30
- PDF
Multifocal motor neuropathy is not associated with genetic variation in PTPN22, BANK1, Blk, FCGR2B, CD1A/E, and TAG‐1 genes
- Biology, Medicine
- Journal of the peripheral nervous system : JPNS
- 2011
- 6
Advances in the diagnosis, pathogenesis and treatment of CIDP
- Medicine
- Nature Reviews Neurology
- 2011
- 187
- PDF
Potential biomarkers for monitoring therapeutic response in patients with CIDP
- Medicine
- Journal of the peripheral nervous system : JPNS
- 2011
- 18
Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies
- Medicine
- Journal of the peripheral nervous system : JPNS
- 2012
- 31
Sialylated IgG-Fc: a novel biomarker of chronic inflammatory demyelinating polyneuropathy
- Medicine
- Journal of Neurology, Neurosurgery & Psychiatry
- 2015
- 16
Intravenous immunoglobulin in neurology—mode of action and clinical efficacy
- Medicine
- Nature Reviews Neurology
- 2015
- 123
References
SHOWING 1-10 OF 46 REFERENCES
Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study.
- Medicine
- Brain : a journal of neurology
- 1996
- 362
- PDF
Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial
- Medicine
- The Lancet Neurology
- 2008
- 471
Evidence of potential interaction of chemokine genes in susceptibility to systemic sclerosis.
- Biology, Medicine
- Arthritis and rheumatism
- 2007
- 25
Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP
- Medicine
- Neurology
- 2005
- 86
Chronic progressive steroid responsive axonal polyneuropathy: A CIDP variant or a primary axonal disorder?
- Medicine
- Muscle & nerve
- 1996
- 41
Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy
- Medicine
- Annals of neurology
- 2001
- 523
Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin
- Medicine
- Annals of neurology
- 1991
- 116
Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies
- Psychology, Medicine
- Journal of neurology, neurosurgery, and psychiatry
- 2002
- 219
- PDF